A total of 449 patients, including 270 CP-CML patients, 85 accelerated-phase (AP) CML patients, 62 blast-phase (BP) CML patients, and 32 Ph+ ALL patients, were enrolled between September 2010 and October 2011. This evidence concerns the gene CP and chronic myelogenous leukemia, BCR-ABL1 positive.